Cargando…
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus‐associated head and neck squamous cell carcinoma
BACKGROUND: The incidence of human papillomavirus (HPV)‐associated (HPV‐positive) head and neck squamous cell carcinoma (HNSCC) of the oropharynx has dramatically increased over the last decade and continues to rise. Newly diagnosed HPV‐positive HNSCCs in the United States currently outnumber any ot...
Autores principales: | Hajek, Michael, Sewell, Andrew, Kaech, Susan, Burtness, Barbara, Yarbrough, Wendell G., Issaeva, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419871/ https://www.ncbi.nlm.nih.gov/pubmed/28295222 http://dx.doi.org/10.1002/cncr.30570 |
Ejemplares similares
-
Selective antitumor activity of roscovitine in head and neck cancer
por: Gary, Cyril, et al.
Publicado: (2016) -
Global Genome Demethylation Causes Transcription-Associated DNA Double Strand Breaks in HPV-Associated Head and Neck Cancer Cells
por: Hajek, Michael, et al.
Publicado: (2020) -
Advances in biomarkers and treatment strategies for HPV-associated head and neck cancer
por: Pan, Cassie, et al.
Publicado: (2018) -
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma
por: Cannataro, Vincent L., et al.
Publicado: (2019) -
Applications of radiomics in precision diagnosis, prognostication and treatment planning of head and neck squamous cell carcinomas
por: Haider, Stefan P., et al.
Publicado: (2020)